Publication List 1996

1984-94, 1995, 1996, 1997, 1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022

15
（126）		 Miyazono K.
Signaling through protein serine/threonine kinase receptors.
In: C.-H. Heldin (ed.) Modular Texts in Molecular and Cell Biology, Vol. 1. Chapman & Hall Ltd., U.K., pp. 65-78.
14
（125）		 Miyazono K.
TGF-β receptors and signal transduction.
In: S. Ikehara, F. Takaku, R.A. Good (eds.) Bone Marrow Transplantation: Basic and Clinical Studies. Springer-Verlag Tokyo, Japan, pp. 124-133.
13
（124）		 Yamashita H, Ten Dijke P, Heldin CH, Miyazono K.
Bone morphogenetic protein receptors.
Bone. 1996 Dec;19(6):569-74.
12
（123）		 Souchelnytskyi S, ten Dijke P, Miyazono K, Heldin CH.
Phosphorylation of Ser165 in TGF-β type I receptor modulates TGF-β1-induced cellular responses.
EMBO J. 1996 Nov 15;15(22):6231-40.
11
（122）		 Harumiya S, Takeda K, Sugiura T, Fukumoto Y, Tachikawa H, Miyazono K, Fujimoto D, Ichijo H.
Characterization of ficolins as novel elastin-binding proteins and molecular cloning of human ficolin-1.
J Biochem. 1996 Oct;120(4):745-51.
10
（121）		 Okadome T, Oeda E, Saitoh M, Ichijo H, Moses HL, Miyazono K, Kawabata M.
Characterization of the interaction of FKBP12 with the transforming growth factor-β type I receptor in vivo.
J Biol Chem. 1996 Sep 6;271(36):21687-90.
9
（120）		 Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Lang S, Kato M, Oefelein MG, Miyazono K, Nemeth JA, Kozlowski JM, Lee C.
Loss of expression of transforming growth factor β type I and type II receptors correlates with tumor grade in human prostate cancer tissues.
Clin Cancer Res. 1996 Aug;2(8):1255-61.
8
（119）		 Nishitoh H, Ichijo H, Kimura M, Matsumoto T, Makishima F, Yamaguchi A, Yamashita H, Enomoto S, Miyazono K.
Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5.
J Biol Chem. 1996 Aug 30;271(35):21345-52.
7
（118）		 Hulth A, Johnell O, Miyazono K, Lindberg L, Heinegård D, Heldin CH.
Effect of transforming growth factor-β and platelet-derived growth factor-BB on articular cartilage in rats.
J Orthop Res. 1996 Jul;14(4):547-53.
6
（117）		 ten Dijke P, Miyazono K, Heldin CH.
Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors.
Curr Opin Cell Biol. 1996 Apr;8(2):139-45.
5
（116）		 Wataya-Kaneda M, Hashimoto K, Kato M, Miyazono K, Yoshikawa K.
Differential localization of TGF-β-precursor isotypes in psoriatic human skin.
J Dermatol Sci. 1996 Mar;11(3):183-8.
4
（115）		 Kai T, Taketazu F, Kawakami M, Shimanuki K, Yamada S, Miyazono K, Kato M, Miyata M.
Distribution of transforming growth factor-β and its receptors in gastric carcinoma tissue.
Jpn J Cancer Res. 1996 Mar;87(3):296-304.
3
（114）		 Yamada N, Kato M, ten Dijke P, Yamashita H, Sampath TK, Heldin CH, Miyazono K, Funa K.
Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours.
Br J Cancer. 1996 Mar;73(5):624-9.
2
（113）		 de Vries CJ, de Boer J, Joore J, Strähle U, van Achterberg TA, Huylebroeck D, Verschueren K, Miyazono K, van den Eijnden-van Raaij AJ, Zivkovic D.
Active complex formation of type I and type II activin and TGFβ receptors in vivo as studied by overexpression in zebrafish embryos.
Mech Dev. 1996 Feb;54(2):225-36.
1
（112）		 Saitoh M, Nishitoh H, Amagasa T, Miyazono K, Takagi M, Ichijo H.
Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-β.
J Biol Chem. 1996 Feb 2;271(5):2769-75.